Funding for this research was provided by:
Agence Nationale de Sécurité du Médicament et des Produits de Santé (2014s029)
Article History
Accepted: 26 February 2023
First Online: 12 April 2023
Declarations
:
: The present study is part of the Drugs Systematized Assessment in real-liFe Environment (DRUGS-SAFE) research program that is funded in part by the French Medicines Agency (Agence Nationale de Sécurité du Médicament et des Produits de Santé, ANSM); grant number 2014s029. This program aims at creating an integrated system for the concomitant monitoring of drug use and safety in France. The potential impact of drugs, the frailty of populations, and the seriousness of risks drive the research program. The funder had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and the decision to submit the manuscript for publication. This publication represents the views of the authors and does not necessarily represent the opinion of the French Medicines Agency.
: All authors declare research grants from the French Medicines Agency (Agence Nationale de Sécurité du Médicament et des Produits de Santé, ANSM).
: This study received the consent of The National Institute for Health Data.
: Not applicable.
: Not applicable.
: Publicly sharing EGB data is forbidden by law according to the French national data protection agency (Commission Nationale de l’Informatique et des LIbertés, CNIL); regulatory decisions AT/CPZ/SVT/JB/DP/CR05222O of 14 June, 2005 and DP/CR071761 of 28 August, 2007. To request data access, please contact The National Institute for Health Data (Institut National des Données de Santé, INDS; website: ExternalRef removed).
: Not applicable.
: LL, JB, and AP contributed to the conception and design; AJ contributed to data acquisition; LL and AJ contributed to data analysis; LL, JB, AJ, and AP contributed to data interpretation; LL contributed to drafting of the article; JB, AJ, and AP critically revised the article for important intellectual content. All authors read and approved the final version of the article.